Cytokine therapeutics for infectious diseases

被引:10
作者
Rodriguez, FH
Nelson, S
Kolls, JK
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Sect Pulm Crit Care, New Orleans, LA 70112 USA
[2] Christian Bros Univ, Dept Biol, Memphis, TN USA
关键词
D O I
10.2174/1381612003400641
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytokines are potent molecules, which function as growth factors and orchestrate both innate and adaptive immune responses. Over the last two decades the number of molecules in this class have greatly expanded, and as the biology of these factors is better understood, several of these factors have entered the clinical arena to support or augment components of the immune response. Recently the use of cytokines/growth factors has been studied in patients without a defective immune system but either have significant infection or infection with drug resistant organisms. The use of cytokines as adjuvants in the treatment of infectious diseases is reviewed both in the context of protein and gene-based therapies.
引用
收藏
页码:665 / 680
页数:16
相关论文
共 136 条
[1]   EXACERBATION OF ACUTE AND CHRONIC MURINE TUBERCULOSIS BY ADMINISTRATION OF A TUMOR-NECROSIS-FACTOR RECEPTOR-EXPRESSING ADENOVIRUS [J].
ADAMS, LB ;
MASON, CM ;
KOLLS, JK ;
SCOLLARD, D ;
KRAHENBUHL, JL ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :400-405
[2]   SPECIFICITY OF A PROTECTIVE MEMORY IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
ANDERSEN, P ;
HERON, I .
INFECTION AND IMMUNITY, 1993, 61 (03) :844-851
[3]   Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor [J].
Armitage, JO .
BLOOD, 1998, 92 (12) :4491-4508
[4]   TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA [J].
BADARO, R ;
FALCOFF, E ;
BADARO, FS ;
CARVALHO, EM ;
PEDRALSAMPAIO, D ;
BARRAL, A ;
CARVALHO, JS ;
BARRALNETTO, M ;
BRANDELY, M ;
SILVA, L ;
BINA, JC ;
TEIXEIRA, R ;
FALCOFF, R ;
ROCHA, H ;
HO, JL ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :16-21
[5]   REDUCTION IN INTENSITY OF PNEUMOCYSTIS-CARINII PNEUMONIA IN MICE BY AEROSOL ADMINISTRATION OF GAMMA-INTERFERON [J].
BECK, JM ;
LIGGITT, HD ;
BRUNETTE, EN ;
FUCHS, HJ ;
SHELLITO, JE ;
DEBS, RJ .
INFECTION AND IMMUNITY, 1991, 59 (11) :3859-3862
[6]   RECOMBINANT HUMAN INTERFERON-GAMMA AS ADJUNCT THERAPY FOR ASPERGILLUS INFECTION IN A PATIENT WITH CHRONIC GRANULOMATOUS-DISEASE [J].
BERNHISELBROADBENT, J ;
CAMARGO, EE ;
JAFFE, HS ;
LEDERMAN, HM .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :908-911
[7]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[8]   THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE [J].
BEUTLER, B ;
CERAMI, A .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :625-655
[9]   Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12 [J].
Bramson, J ;
Hitt, M ;
Gallichan, WS ;
Rosenthal, KL ;
Gauldie, J ;
Graham, FL .
HUMAN GENE THERAPY, 1996, 7 (03) :333-342
[10]  
BURGESS AW, 1987, BLOOD, V69, P43